To the full analysis
Buyback calculator for NeoGenomics
NeoGenomics stock: dividend
NEONeoGenomics does not currently pay a dividend; its last payment went ex on 17 Dec 2020. NeoGenomics did not buy back any of its own shares from fiscal 2023 to 2025.
Whether NeoGenomics, Inc. pays a dividend and what the company does with its cash instead: free cash flow, buybacks of its own shares and the share count over recent years.
Daily figure as of 13 Nov 2026
Dividend dates and payments
Anyone holding the stock on the day before the ex-dividend date receives the dividend. Amounts are per share, before tax.
Last ex-dividend date
17 Dec 2020
$0.40, paid 30 Dec 2020
Next ex-dividend date
not announced yet
Frequency
irregular
Free cash flow and buybacks
| Fiscal year | Free cash flow | Share buybacks | Shares outstanding |
|---|---|---|---|
| 2025 | −$21.78M | $0 | 128.10M |
| 2024 | −$34.04M | $0 | 126.66M |
| 2023 | −$30.71M | $0 | 125.50M |
| 2022 | −$96.88M | $0 | 124.22M |
| 2021 | −$90.87M | $0 | 119.96M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Jan 2020)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.